top of page

News & History

2023-11

SIVA being used as the first continuous AI-based ambulatory cough measurement system in a global drug development study, providing cough profiles over several weeks

2023-11

Completion of the European Union Medical Device Regulation (MDR) final audit. An important step in obtaining an MDR certificate and CE marking, confirming SIVA Healths' compliance with the highest required regulatory standards.

2023-09

Participation at European Respiratory Society Congress 2023

in Milan

2023-07

SIVA Health AG becoming a fully independent company

2023-06

SIVA Health participating in the American Cough Conference 2023 in Washington DC

2023-03

Start of clinical validation study in the U.S. at the Bellingham Asthma,

Allergy & Immunology Clinic
ClinicalTrials.gov / Identifier: NCT05689307

2022-10

Clinical results of the SIVA validation study published in

ERJ Open Research

First publication on continuous cough monitoring over several weeks with a large number of patients.

2022-09

Poster Presentation at European Respiratory Society Congress 2022 in Barcelona

2022-03

Poster Presentation at the Swiss Society of Pneumology Congress 2022 in Lucerne

2021-04

Start of clinical validation study at the University Hospital Zurich

First study on continuous cough monitoring over several weeks with a large number of patients

2020-04

Initiation of continuous AI-based ambulatory cough monitoring project in close collaboration with Bayer Pharmaceuticals

bottom of page